-
1
-
-
70349735887
-
Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNγ but have a spectrum of IL-17 profiles
-
19692128 10.1016/j.jneuroim.2009.07.007 1:CAS:528:DC%2BD1MXht1Gmt7%2FF 2761534
-
Abromson-Leeman S, Bronson RT, Dorf ME (2009) Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNγ but have a spectrum of IL-17 profiles. J Neuroimmunol 215:10-24
-
(2009)
J Neuroimmunol
, vol.215
, pp. 10-24
-
-
Abromson-Leeman, S.1
Bronson, R.T.2
Dorf, M.E.3
-
2
-
-
79953697662
-
5-HT and the immune system
-
21393060 10.1016/j.coph.2011.02.004 1:CAS:528:DC%2BC3MXks1WqsrY%3D 3144148
-
Ahern GP (2011) 5-HT and the immune system. Curr Opin Pharmacol 11:29-33
-
(2011)
Curr Opin Pharmacol
, vol.11
, pp. 29-33
-
-
Ahern, G.P.1
-
3
-
-
84863803849
-
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
-
22547654 10.1084/jem.20111675 1:CAS:528:DC%2BC38Xmsl2itb0%3D 3348102
-
Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S, Fan B, O'Connor RA, Anderton SM, Bar-Or A, Fillatreau S, Gray D (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209:1001-1010
-
(2012)
J Exp Med
, vol.209
, pp. 1001-1010
-
-
Barr, T.A.1
Shen, P.2
Brown, S.3
Lampropoulou, V.4
Roch, T.5
Lawrie, S.6
Fan, B.7
O'Connor, R.A.8
Anderton, S.M.9
Bar-Or, A.10
Fillatreau, S.11
Gray, D.12
-
4
-
-
33847420442
-
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
-
17329437 10.1523/JNEUROSCI.4814-06.2007 1:CAS:528:DC%2BD2sXjsVymsLY%3D
-
Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J (2007) Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27:2396-2402
-
(2007)
J Neurosci
, vol.27
, pp. 2396-2402
-
-
Benito, C.1
Romero, J.P.2
Tolón, R.M.3
Clemente, D.4
Docagne, F.5
Hillard, C.J.6
Guaza, C.7
Romero, J.8
-
5
-
-
0019986548
-
Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells
-
6177753 1:STN:280:DyaL383hsFWisg%3D%3D
-
Ben-Nun A, Cohen IR (1982) Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 129:303-308
-
(1982)
J Immunol
, vol.129
, pp. 303-308
-
-
Ben-Nun, A.1
Cohen, I.R.2
-
6
-
-
0023879766
-
Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma
-
3126227 1:CAS:528:DyaL1cXhs1Gqtr8%3D
-
Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H (1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140:1506-1510
-
(1988)
J Immunol
, vol.140
, pp. 1506-1510
-
-
Billiau, A.1
Heremans, H.2
Vandekerckhove, F.3
Dijkmans, R.4
Sobis, H.5
Meulepas, E.6
Carton, H.7
-
7
-
-
80051664599
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
Booz GW (2011) Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med 1054-1061
-
(2011)
Free Radic Biol Med
, pp. 1054-1061
-
-
Booz, G.W.1
-
8
-
-
0034457826
-
Cell contact-mediated signaling of monocytes by stimulated T cells: A major pathway for cytokine induction
-
11022117 1:CAS:528:DC%2BD3cXotFKqsLk%3D
-
Burger D (2000) Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction. Eur Cytokine Netw 11:346-353
-
(2000)
Eur Cytokine Netw
, vol.11
, pp. 346-353
-
-
Burger, D.1
-
9
-
-
77952493930
-
Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors
-
20098669 10.1371/journal.pone.0008688 2809084
-
Cencioni MT, Chiurchiù V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M (2010) Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 5:e8688
-
(2010)
PLoS One
, vol.5
, pp. 8688
-
-
Cencioni, M.T.1
Chiurchiù, V.2
Catanzaro, G.3
Borsellino, G.4
Bernardi, G.5
Battistini, L.6
MacCarrone, M.7
-
10
-
-
79954937143
-
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
-
21310228 10.1016/j.bbi.2011.01.020 1:CAS:528:DC%2BC3MXltFOrtbs%3D
-
Correa F, Hernangómez-Herrero M, Mestre L, Loría F, Docagne F, Guaza C (2011) The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells. Brain Behav Immun 25:736-749
-
(2011)
Brain Behav Immun
, vol.25
, pp. 736-749
-
-
Correa, F.1
Hernangómez-Herrero, M.2
Mestre, L.3
Loría, F.4
Docagne, F.5
Guaza, C.6
-
11
-
-
46249121074
-
Effect of cannabidiol on sepsis-induced motility disturbances in mice: Involvement of CB receptors and fatty acid amide hydrolase
-
10.1111/j.1365-2982.2008.01114.x
-
De Filippis D, Iuvone T, D'Amico A, Esposito G, Steardo L, Herman AG, Pelckmans PA, de Winter BY, de Man JG (2008) Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase. Neurogastroenterol Motil 8:919-927
-
(2008)
Neurogastroenterol Motil
, vol.8
, pp. 919-927
-
-
De Filippis, D.1
Iuvone, T.2
D'Amico, A.3
Esposito, G.4
Steardo, L.5
Herman, A.G.6
Pelckmans, P.A.7
De Winter, B.Y.8
De Man, J.G.9
-
12
-
-
82755165068
-
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
-
10.1371/journal.pone.0028159 22163000 10.1371/journal.pone.0028159 3232190
-
De Filippis D, Esposito G, Cirillo C, Cipriano M, De Winter BY, Scuderi C, Sarnelli G, Cuomo R, Steardo L, De Man JG, Iuvone T (2011) Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One 6:e28159. doi: 10.1371/journal.pone.0028159
-
(2011)
PLoS One
, vol.6
, pp. 28159
-
-
De Filippis, D.1
Esposito, G.2
Cirillo, C.3
Cipriano, M.4
De Winter, B.Y.5
Scuderi, C.6
Sarnelli, G.7
Cuomo, R.8
Steardo, L.9
De Man, J.G.10
Iuvone, T.11
-
13
-
-
30344486638
-
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
-
16400026 10.2353/ajpath.2006.050500 1:CAS:528:DC%2BD28XhtVKktr4%3D 1592672
-
El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI (2006) Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168:235-244
-
(2006)
Am J Pathol
, vol.168
, pp. 235-244
-
-
El-Remessy, A.B.1
Al-Shabrawey, M.2
Khalifa, Y.3
Tsai, N.T.4
Caldwell, R.B.5
Liou, G.I.6
-
14
-
-
82655189157
-
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
-
10.1371/journal.pone.0028668 22163051 10.1371/journal.pone.0028668 1:CAS:528:DC%2BC3MXhs1Kht73J 3230631
-
Esposito G, Scuderi C, Valenza M, Togna GI, Latina V, De Filippis D, Cipriano M, Carratù MR, Iuvone T, Steardo L (2011) Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement. PLoS One 6:e28668. doi: 10.1371/journal.pone.0028668
-
(2011)
PLoS One
, vol.6
, pp. 28668
-
-
Esposito, G.1
Scuderi, C.2
Valenza, M.3
Togna, G.I.4
Latina, V.5
De Filippis, D.6
Cipriano, M.7
Carratù, M.R.8
Iuvone, T.9
Steardo, L.10
-
15
-
-
77955489317
-
Anti-TNF therapy, from rationale to standard of care: What lessons has it taught us?
-
20601610 10.4049/jimmunol.1090051 1:CAS:528:DC%2BC3cXotlymu78%3D
-
Feldmann M, Maini RN (2010) Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us? J Immunol 185:791-794
-
(2010)
J Immunol
, vol.185
, pp. 791-794
-
-
Feldmann, M.1
Maini, R.N.2
-
16
-
-
0029671318
-
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
-
8598493 1:CAS:528:DyaK28XlsVGj
-
Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5-7
-
(1996)
J Immunol
, vol.156
, pp. 5-7
-
-
Ferber, I.A.1
Brocke, S.2
Taylor-Edwards, C.3
Ridgway, W.4
Dinisco, C.5
Steinman, L.6
Dalton, D.7
Fathman, C.G.8
-
17
-
-
55149123753
-
Th17 cytokines and their emerging roles in inflammation and autoimmunity
-
19161418 10.1111/j.1600-065X.2008.00712.x 1:CAS:528:DC%2BD1MXhsFGls77J
-
Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M (2008) Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226:87-102
-
(2008)
Immunol Rev
, vol.226
, pp. 87-102
-
-
Fouser, L.A.1
Wright, J.F.2
Dunussi-Joannopoulos, K.3
Collins, M.4
-
18
-
-
27544490377
-
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
-
16200070 10.1038/ni1254 1:CAS:528:DC%2BD2MXhtFamsb7J
-
Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Weaver CT (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132
-
(2005)
Nat Immunol
, vol.6
, pp. 1123-1132
-
-
Harrington, L.E.1
Hatton, R.D.2
Mangan, P.R.3
Turner, H.4
Murphy, T.L.5
Weaver, C.T.6
-
19
-
-
79953658580
-
Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol
-
21483776 10.1371/journal.pone.0018281 1:CAS:528:DC%2BC3MXkvVekur0%3D 3069975
-
Hegde VL, Nagarkatti PS, Nagarkatti M (2011) Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 6:e18281
-
(2011)
PLoS One
, vol.6
, pp. 18281
-
-
Hegde, V.L.1
Nagarkatti, P.S.2
Nagarkatti, M.3
-
20
-
-
0021929098
-
Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies
-
2983062 1:CAS:528:DyaL2MXktVSntL0%3D
-
Hillard CJ, Harris RA, Bloom AS (1985) Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies. J Pharmacol Exp Ther 232:579-588
-
(1985)
J Pharmacol Exp Ther
, vol.232
, pp. 579-588
-
-
Hillard, C.J.1
Harris, R.A.2
Bloom, A.S.3
-
21
-
-
70349189518
-
Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb
-
19729208 10.1016/j.tips.2009.07.006 1:CAS:528:DC%2BD1MXhtFyqtbzF
-
Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515-527
-
(2009)
Trends Pharmacol Sci
, vol.30
, pp. 515-527
-
-
Izzo, A.A.1
Borrelli, F.2
Capasso, R.3
Di Marzo, V.4
Mechoulam, R.5
-
22
-
-
84876556444
-
Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells
-
23637839 10.1371/journal.pone.0061462 1:CAS:528:DC%2BC3sXntVOisb0%3D 3634783
-
Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Gao F, Coppola G, Geschwind D, Vogel Z (2013) Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells. PLoS One 8:e61462
-
(2013)
PLoS One
, vol.8
, pp. 61462
-
-
Juknat, A.1
Pietr, M.2
Kozela, E.3
Rimmerman, N.4
Levy, R.5
Gao, F.6
Coppola, G.7
Geschwind, D.8
Vogel, Z.9
-
23
-
-
0042934012
-
Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes
-
12805480 10.1124/jpet.103.051961 1:CAS:528:DC%2BD3sXmvVehtL8%3D
-
Kaplan BL, Rockwell CE, Kaminski NE (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J Pharmacol Exp Ther 306:1077-1085
-
(2003)
J Pharmacol Exp Ther
, vol.306
, pp. 1077-1085
-
-
Kaplan, B.L.1
Rockwell, C.E.2
Kaminski, N.E.3
-
24
-
-
21244437089
-
Autoimmune CD4+ T cell memory: Lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires
-
1:CAS:528:DC%2BD2MXltlymsLc%3D
-
Kawakami N, Odoardi F, Ziemssen T, Bradl M, Ritter T, Neuhaus O, Lassmann H, Wekerle H, Flügel AJ (2005) Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. Immunology 175:69-81
-
(2005)
Immunology
, vol.175
, pp. 69-81
-
-
Kawakami, N.1
Odoardi, F.2
Ziemssen, T.3
Bradl, M.4
Ritter, T.5
Neuhaus, O.6
Lassmann, H.7
Wekerle, H.8
Flügel, A.J.9
-
25
-
-
34948909646
-
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
-
17828272 10.1038/nm1651 1:CAS:528:DC%2BD2sXhtFagsbzK
-
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173-1175
-
(2007)
Nat Med
, vol.13
, pp. 1173-1175
-
-
Kebir, H.1
Kreymborg, K.2
Ifergan, I.3
Dodelet-Devillers, A.4
Cayrol, R.5
Bernard, M.6
Giuliani, F.7
Arbour, N.8
Becher, B.9
Prat, A.10
-
26
-
-
33745321276
-
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
-
16785554 1:CAS:528:DC%2BD28XlvV2ntbg%3D
-
Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573
-
(2006)
J Immunol
, vol.177
, pp. 566-573
-
-
Komiyama, Y.1
Nakae, S.2
Matsuki, T.3
Nambu, A.4
Ishigame, H.5
Kakuta, S.6
Sudo, K.7
Iwakura, Y.8
-
27
-
-
76249095734
-
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NFkappaB and interferon-β/STAT proinflammatory pathways in BV-2 microglial cells
-
19910459 10.1074/jbc.M109.069294 1:CAS:528:DC%2BC3cXjsVSntw%3D%3D 2804319
-
Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z (2010) Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NFkappaB and interferon-β/STAT proinflammatory pathways in BV-2 microglial cells. J Biol Chem 285:1616-1626
-
(2010)
J Biol Chem
, vol.285
, pp. 1616-1626
-
-
Kozela, E.1
Pietr, M.2
Juknat, A.3
Rimmerman, N.4
Levy, R.5
Vogel, Z.6
-
28
-
-
79960293903
-
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
-
21449980 10.1111/j.1476-5381.2011.01379.x 1:CAS:528:DC%2BC3MXps1Sis78%3D 3165959
-
Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z (2011) Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol 163:1507-1519
-
(2011)
Br J Pharmacol
, vol.163
, pp. 1507-1519
-
-
Kozela, E.1
Lev, N.2
Kaushansky, N.3
Eilam, R.4
Rimmerman, N.5
Levy, R.6
Ben-Nun, A.7
Juknat, A.8
Vogel, Z.9
-
29
-
-
0033546665
-
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
-
Lenercept Multiple Sclerosis Study Group, and the University of British Columbia MS/MRI Analysis Group 10.1212/WNL.53.3.457
-
Lenercept Multiple Sclerosis Study Group, and the University of British Columbia MS/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53:457-465
-
(1999)
Neurology
, vol.53
, pp. 457-465
-
-
-
30
-
-
33747624175
-
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
-
16728591 10.1124/jpet.106.105247 1:CAS:528:DC%2BD28XovFygtLY%3D
-
Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318:1375-1387
-
(2006)
J Pharmacol Exp Ther
, vol.318
, pp. 1375-1387
-
-
Ligresti, A.1
Moriello, A.S.2
Starowicz, K.3
Matias, I.4
Pisanti, S.5
De Petrocellis, L.6
Laezza, C.7
Portella, G.8
Bifulco, M.9
Di Marzo, V.10
-
31
-
-
0031933496
-
The cytokine storm in multiple sclerosis
-
9532586 10.1191/135245898678909141 1:CAS:528:DyaK1cXitVGrurs%3D
-
Link H (1998) The cytokine storm in multiple sclerosis. Mult Scler 4:12-15
-
(1998)
Mult Scler
, vol.4
, pp. 12-15
-
-
Link, H.1
-
32
-
-
0031916192
-
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
-
9427610 10.1038/nm0198-078 1:CAS:528:DyaK1cXjt1Kgsg%3D%3D
-
Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78-83
-
(1998)
Nat Med
, vol.4
, pp. 78-83
-
-
Liu, J.1
Marino, M.W.2
Wong, G.3
Grail, D.4
Dunn, A.5
Bettadapura, J.6
Slavin, A.J.7
Old, L.8
Bernard, C.C.9
-
33
-
-
0342906187
-
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
-
10852536 10.1002/1531-8249(200006)47:6<707: AID-ANA3>3.0.CO;2-Q 1:STN:280:DC%2BD3czgvFektA%3D%3D
-
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
-
(2000)
Ann Neurol
, vol.47
, pp. 707-717
-
-
Lucchinetti, C.1
Brück, W.2
Parisi, J.3
Scheithauer, B.4
Rodriguez, M.5
Lassmann, H.6
-
34
-
-
0024596492
-
Delta 9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalomyelitis
-
2542370 10.1016/0165-5728(89)90075-1 1:CAS:528:DyaL1MXktlegs7s%3D
-
Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB (1989) Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol 23:73-81
-
(1989)
J Neuroimmunol
, vol.23
, pp. 73-81
-
-
Lyman, W.D.1
Sonett, J.R.2
Brosnan, C.F.3
Elkin, R.4
Bornstein, M.B.5
-
35
-
-
33645774927
-
Distribution of cannabinoid receptors in the central and peripheral nervous system
-
16596779 10.1007/3-540-26573-2-10 1:CAS:528:DC%2BD2MXkvFeqsL0%3D
-
Mackie K (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168:299-325
-
(2005)
Handb Exp Pharmacol
, vol.168
, pp. 299-325
-
-
MacKie, K.1
-
36
-
-
84862695017
-
Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies
-
22640807 10.1016/j.ajpath.2012.03.044 1:CAS:528:DC%2BC38XhtFOitbbF
-
Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181:8-18
-
(2012)
Am J Pathol
, vol.181
, pp. 8-18
-
-
Maddur, M.S.1
Miossec, P.2
Kaveri, S.V.3
Bayry, J.4
-
37
-
-
0034662868
-
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
-
10920191 10.1073/pnas.160105897 1:CAS:528:DC%2BD3cXmtVensbs%3D 16904
-
Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci 97:9561-9566
-
(2000)
Proc Natl Acad Sci
, vol.97
, pp. 9561-9566
-
-
Malfait, A.M.1
Gallily, R.2
Sumariwalla, P.F.3
Malik, A.S.4
Andreakos, E.5
Mechoulam, R.6
Feldmann, M.7
-
38
-
-
34147165471
-
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
-
17401376 10.1038/nm1561 1:CAS:528:DC%2BD2sXjvVaqur8%3D
-
Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13:492-497
-
(2007)
Nat Med
, vol.13
, pp. 492-497
-
-
Maresz, K.1
Pryce, G.2
Ponomarev, E.D.3
Marsicano, G.4
Croxford, J.L.5
Shriver, L.P.6
Ledent, C.7
Cheng, X.8
Carrier, E.J.9
Mann, M.K.10
Giovannoni, G.11
Pertwee, R.G.12
Yamamura, T.13
Buckley, N.E.14
Hillard, C.J.15
Lutz, B.16
Baker, D.17
Dittel, B.N.18
-
39
-
-
0344389016
-
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
-
10335518 1:CAS:528:DyaK1MXjtFyms70%3D
-
Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, Fredrikson S, Link H (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5:101-104
-
(1999)
Mult Scler
, vol.5
, pp. 101-104
-
-
Matusevicius, D.1
Kivisäkk, P.2
He, B.3
Kostulas, N.4
Ozenci, V.5
Fredrikson, S.6
Link, H.7
-
40
-
-
18244396915
-
Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism
-
15845890 10.1161/01.STR.0000163083.59201.34
-
Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K, Fujiwara M (2005) Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36:1077-1082
-
(2005)
Stroke
, vol.36
, pp. 1077-1082
-
-
Mishima, K.1
Hayakawa, K.2
Abe, K.3
Ikeda, T.4
Egashira, N.5
Iwasaki, K.6
Fujiwara, M.7
-
41
-
-
52949101057
-
Viability and function in lymphocytes cultured from the horse, chicken, and mouse: Effects of different leukocyte enrichment techniques
-
10.1080/15321810802329823 1:CAS:528:DC%2BD1cXhtFKmurjM
-
Mustafa A, Gillmeister L, Hernandez WP, Larsen CT, Witonsky S, Holladay SD, Kerr RP, Ahmed SA, Santo A, Gogal RM Jr (2008) Viability and function in lymphocytes cultured from the horse, chicken, and mouse: effects of different leukocyte enrichment techniques. J Immunoass Immunochem 29:370-389
-
(2008)
J Immunoass Immunochem
, vol.29
, pp. 370-389
-
-
Mustafa, A.1
Gillmeister, L.2
Hernandez, W.P.3
Larsen, C.T.4
Witonsky, S.5
Holladay, S.D.6
Kerr, R.P.7
Ahmed, S.A.8
Santo, A.9
Gogal, Jr.R.M.10
-
42
-
-
77953451267
-
Cannabinoids as novel anti-inflammatory drugs
-
20191092 10.4155/fmc.09.93 1:CAS:528:DC%2BD1MXhtlOisL%2FN 2828614
-
Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1:1333-1349
-
(2009)
Future Med Chem
, vol.1
, pp. 1333-1349
-
-
Nagarkatti, P.1
Pandey, R.2
Rieder, S.A.3
Hegde, V.L.4
Nagarkatti, M.5
-
43
-
-
0031822204
-
The role of macrophages in THC-induced alteration of the cytokine network
-
9666273 10.1007/978-1-4615-5347-2-23 1:CAS:528:DyaK1cXmvFGksrw%3D
-
Newton C, Klein T, Friedman H (1998) The role of macrophages in THC-induced alteration of the cytokine network. Adv Exp Med Biol 437:207-214
-
(1998)
Adv Exp Med Biol
, vol.437
, pp. 207-214
-
-
Newton, C.1
Klein, T.2
Friedman, H.3
-
44
-
-
84867894231
-
Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors
-
23059426 10.1038/nri3321 1:CAS:528:DC%2BC38XhsV2rs7fL 3584691
-
Oestreich KJ, Weinmann AS (2012) Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors. Nat Rev Immunol 12:799-804
-
(2012)
Nat Rev Immunol
, vol.12
, pp. 799-804
-
-
Oestreich, K.J.1
Weinmann, A.S.2
-
45
-
-
77954175115
-
Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
-
19833407 10.1016/j.imbio.2009.09.007
-
O'Sullivan SE, Kendall DA (2010) Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 215:611-616
-
(2010)
Immunobiology
, vol.215
, pp. 611-616
-
-
O'Sullivan, S.E.1
Kendall, D.A.2
-
46
-
-
0023221133
-
Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system
-
3110648 10.1212/WNL.37.7.1097 1:STN:280:DyaL2s3lvVOksQ%3D%3D
-
Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097-1102
-
(1987)
Neurology
, vol.37
, pp. 1097-1102
-
-
Panitch, H.S.1
Hirsch, R.L.2
Schindler, J.3
Johnson, K.P.4
-
47
-
-
84878128163
-
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors
-
23587650 10.1016/j.neuropharm.2013.03.027 1:CAS:528:DC%2BC3sXoslWlur0%3D
-
Pazos MR, Mohammed N, Lafuente H, Santos M, Martínez-Pinilla E, Moreno E, Valdizan E, Romero J, Pazos A, Franco R, Hillard CJ, Alvarez FJ, Martínez-Orgado J (2013) Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT1A and CB2 receptors. Neuropharmacology 71:282-291
-
(2013)
Neuropharmacology
, vol.71
, pp. 282-291
-
-
Pazos, M.R.1
Mohammed, N.2
Lafuente, H.3
Santos, M.4
Martínez-Pinilla, E.5
Moreno, E.6
Valdizan, E.7
Romero, J.8
Pazos, A.9
Franco, R.10
Hillard, C.J.11
Alvarez, F.J.12
Martínez-Orgado, J.13
-
48
-
-
12744258029
-
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
-
15670612 10.1016/j.lfs.2004.10.025 1:CAS:528:DC%2BD2MXntVSksQ%3D%3D
-
Pertwee RG (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 76:1307-1324
-
(2005)
Life Sci
, vol.76
, pp. 1307-1324
-
-
Pertwee, R.G.1
-
49
-
-
0034023285
-
Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients
-
10694841 1:STN:280:DC%2BD3c7mtFShtg%3D%3D
-
Petereit HF, Richter N, Pukrop R, Bamborschke S (2000) Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients. Mult Scler 6:19-23
-
(2000)
Mult Scler
, vol.6
, pp. 19-23
-
-
Petereit, H.F.1
Richter, N.2
Pukrop, R.3
Bamborschke, S.4
-
50
-
-
0033986604
-
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
-
10594923 10.1002/(SICI)1098-1136(20000101)29:1<58: AID-GLIA6>3.0.CO;2-W 1:STN:280:DC%2BD3c%2Fmt1Orsg%3D%3D
-
Puffenbarger RA, Boothe AC, Cabral GA (2000) Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29:58-69
-
(2000)
Glia
, vol.29
, pp. 58-69
-
-
Puffenbarger, R.A.1
Boothe, A.C.2
Cabral, G.A.3
-
51
-
-
77954175124
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
-
19457575 10.1016/j.imbio.2009.04.001 1:CAS:528:DC%2BC3cXpsVCks70%3D 3005548
-
Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P (2010) Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology 215:598-560
-
(2010)
Immunobiology
, vol.215
, pp. 598-560
-
-
Rieder, S.A.1
Chauhan, A.2
Singh, U.3
Nagarkatti, M.4
Nagarkatti, P.5
-
52
-
-
85027927333
-
The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells
-
21533611 10.1007/s10571-011-9692-3 1:CAS:528:DC%2BC3MXps1Wit70%3D
-
Rimmerman N, Juknat A, Kozela E, Levy R, Bradshaw HB, Vogel Z (2011) The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells. Cell Mol Neurobiol 31:921-930
-
(2011)
Cell Mol Neurobiol
, vol.31
, pp. 921-930
-
-
Rimmerman, N.1
Juknat, A.2
Kozela, E.3
Levy, R.4
Bradshaw, H.B.5
Vogel, Z.6
-
53
-
-
84876549166
-
Cannabinoid signaling through non-CB1, -non-CB2 GPCR targets in microglia
-
M.E. Abood R.G. Sorensen N. Stella (eds) Springer New York 10.1007/978-1-4614-4669-9-7
-
Rimmerman N, Kozela E, Levy R, Vogel Z, Juknat A (2013) Cannabinoid signaling through non-CB1, -non-CB2 GPCR targets in microglia. In: Abood ME, Sorensen RG, Stella N (eds) Endocannabinoids: actions at non-CB1/CB2 cannabinoid receptors. Springer, New York, pp 143-171
-
(2013)
Endocannabinoids: Actions at non-CB1/CB2 Cannabinoid Receptors
, pp. 143-171
-
-
Rimmerman, N.1
Kozela, E.2
Levy, R.3
Vogel, Z.4
Juknat, A.5
-
54
-
-
0028245010
-
Interleukin-10 prevents experimental allergic encephalomyelitis in rats
-
7515815 10.1002/eji.1830240629 1:CAS:528:DyaK2cXkvVSltLs%3D
-
Rott O, Fleischer B, Cash E (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24:1434-1440
-
(1994)
Eur J Immunol
, vol.24
, pp. 1434-1440
-
-
Rott, O.1
Fleischer, B.2
Cash, E.3
-
55
-
-
73149121261
-
A major lipid raft protein raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses
-
19414744 10.4049/jimmunol.0802672 1:CAS:528:DC%2BD1MXltlynsrg%3D
-
Saeki K, Fukuyama S, Ayada T, Nakaya M, Aki D, Takaesu G, Hanada T, Matsumura Y, Kobayashi T, Nakagawa R, Yoshimura A (2009) A major lipid raft protein raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses. J Immunol 182:5929-3597
-
(2009)
J Immunol
, vol.182
, pp. 5929-3597
-
-
Saeki, K.1
Fukuyama, S.2
Ayada, T.3
Nakaya, M.4
Aki, D.5
Takaesu, G.6
Hanada, T.7
Matsumura, Y.8
Kobayashi, T.9
Nakagawa, R.10
Yoshimura, A.11
-
56
-
-
0032534730
-
IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
-
9862671 1:CAS:528:DyaK1cXotFWqs7c%3D
-
Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161:6480-6486
-
(1998)
J Immunol
, vol.161
, pp. 6480-6486
-
-
Samoilova, E.B.1
Horton, J.L.2
Hilliard, B.3
Liu, T.S.4
Chen, Y.5
-
57
-
-
79960296602
-
Animal models for autoimmune and inflammatory diseases
-
J.E. Coligan A.M. Kruisbeek D.H. Margulies E.M. Shevach W. Strober (eds) John Wiley & Sons New York
-
Shevach EM (2011) Animal models for autoimmune and inflammatory diseases. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds) Current protocols in immunology. John Wiley & Sons, New York, pp 15.0.1-15.0.5
-
(2011)
Current Protocols in Immunology
, pp. 1501-1505
-
-
Shevach, E.M.1
-
58
-
-
0030425575
-
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
-
8819477 1:CAS:528:DyaK28XmtVSjs74%3D
-
Showalter VM, Compton DR, Martin BR, Abood ME (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999
-
(1996)
J Pharmacol Exp Ther
, vol.278
, pp. 989-999
-
-
Showalter, V.M.1
Compton, D.R.2
Martin, B.R.3
Abood, M.E.4
-
59
-
-
77957056123
-
In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis
-
20870176 10.1016/j.immuni.2010.08.018 1:CAS:528:DC%2BC3cXht1SntLnK
-
Siffrin V, Radbruch H, Glumm R, Niesner R, Paterka M, Herz J, Leuenberger T, Lehmann SM, Luenstedt S, Rinnenthal JL, Laube G, Luche H, Lehnardt S, Fehling HJ, Griesbeck O, Zipp F (2010) In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33:424-436
-
(2010)
Immunity
, vol.33
, pp. 424-436
-
-
Siffrin, V.1
Radbruch, H.2
Glumm, R.3
Niesner, R.4
Paterka, M.5
Herz, J.6
Leuenberger, T.7
Lehmann, S.M.8
Luenstedt, S.9
Rinnenthal, J.L.10
Laube, G.11
Luche, H.12
Lehnardt, S.13
Fehling, H.J.14
Griesbeck, O.15
Zipp, F.16
-
60
-
-
17644396349
-
Immunology of multiple sclerosis
-
15771584 10.1146/annurev.immunol.23.021704.115707 1:CAS:528: DC%2BD2MXktFOju7w%3D
-
Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 683-747
-
-
Sospedra, M.1
Martin, R.2
-
61
-
-
33846966636
-
A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage
-
17290272 10.1038/nm1551 1:CAS:528:DC%2BD2sXhsVykuro%3D
-
Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139-145
-
(2007)
Nat Med
, vol.13
, pp. 139-145
-
-
Steinman, L.1
-
62
-
-
42449086335
-
Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice
-
18362339 10.1073/pnas.0712131105 1:CAS:528:DC%2BD1cXksVCqt7k%3D 2278190
-
Stern JN, Keskin DB, Zhang H, Lv H, Kato Z, Strominger JL (2008) Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc Natl Acad Sci U S A 105:5172-5176
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 5172-5176
-
-
Stern, J.N.1
Keskin, D.B.2
Zhang, H.3
Lv, H.4
Kato, Z.5
Strominger, J.L.6
-
63
-
-
77954177664
-
Cannabinoids and the immune system: An overview
-
20153077 10.1016/j.imbio.2009.12.005 1:CAS:528:DC%2BC3cXpsVCks7w%3D
-
Tanasescu R, Constantinescu CS (2010) Cannabinoids and the immune system: an overview. Immunobiology 215:588-597
-
(2010)
Immunobiology
, vol.215
, pp. 588-597
-
-
Tanasescu, R.1
Constantinescu, C.S.2
-
64
-
-
0034332949
-
Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis
-
11063821 10.1016/S0165-5728(00)00384-2 1:CAS:528:DC%2BD3cXovVyltbo%3D
-
Tuohy VK, Yu M, Yin L, Mathisen PM, Johnson JM, Kawczak JA (2000) Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. J Neuroimmunol 111:55-63
-
(2000)
J Neuroimmunol
, vol.111
, pp. 55-63
-
-
Tuohy, V.K.1
Yu, M.2
Yin, L.3
Mathisen, P.M.4
Johnson, J.M.5
Kawczak, J.A.6
-
65
-
-
32244442562
-
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
-
16473830 10.1016/j.immuni.2006.01.001 1:CAS:528:DC%2BD28XitVOks7s%3D
-
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189
-
(2006)
Immunity
, vol.24
, pp. 179-189
-
-
Veldhoen, M.1
Hocking, R.J.2
Atkins, C.J.3
Locksley, R.M.4
Stockinger, B.5
-
66
-
-
60549104213
-
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE
-
10.1007/s00109-008-0421-4
-
van Zwam M, Huizinga R, Melief MJ, Wierenga-Wolf AF, van Meurs M, Voerman JS, Biber KP, Boddeke HW, Höpken UE, Meisel C, Meisel A, Bechmann I, Hintzen RQ, 't Hart BA, Amor S, Laman JD, Boven LA (2009) Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl) 87:273-286
-
(2009)
J Mol Med (Berl)
, vol.87
, pp. 273-286
-
-
Van Zwam, M.1
Huizinga, R.2
Melief, M.J.3
Wierenga-Wolf, A.F.4
Van Meurs, M.5
Voerman, J.S.6
Biber, K.P.7
Boddeke, H.W.8
Höpken, U.E.9
Meisel, C.10
Meisel, A.11
Bechmann, I.12
Hintzen, R.Q.13
'T Hart, B.A.14
Amor, S.15
Laman, J.D.16
Boven, L.A.17
-
67
-
-
33646404921
-
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
-
16698671 10.1080/08916930500356674 1:CAS:528:DC%2BD28XktVyntrc%3D
-
Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R (2006) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 39:143-151
-
(2006)
Autoimmunity
, vol.39
, pp. 143-151
-
-
Weiss, L.1
Zeira, M.2
Reich, S.3
Har-Noy, M.4
Mechoulam, R.5
Slavin, S.6
Gallily, R.7
-
68
-
-
0032928662
-
Remembering MOG: Autoantibody mediated demyelination in multiple sclerosis?
-
9930860 10.1038/5514 1:STN:280:DyaK1M7ivVSmsg%3D%3D
-
Wekerle H (1999) Remembering MOG: autoantibody mediated demyelination in multiple sclerosis? Nat Med 5:153-154
-
(1999)
Nat Med
, vol.5
, pp. 153-154
-
-
Wekerle, H.1
-
69
-
-
0030587910
-
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
-
8871615 1:CAS:528:DyaK28Xmtlahtbw%3D
-
Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA (1996) IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157:3223-3227
-
(1996)
J Immunol
, vol.157
, pp. 3223-3227
-
-
Willenborg, D.O.1
Fordham, S.2
Bernard, C.C.3
Cowden, W.B.4
Ramshaw, I.A.5
-
70
-
-
0035421324
-
Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE)
-
11488634 10.1006/jaut.2001.0520 1:STN:280:DC%2BD3MvktlKgtg%3D%3D
-
Yura M, Takahashi I, Serada M, Koshio T, Nakagami K, Yuki Y, Kiyono H (2001) Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE). J Autoimmun 17:17-25
-
(2001)
J Autoimmun
, vol.17
, pp. 17-25
-
-
Yura, M.1
Takahashi, I.2
Serada, M.3
Koshio, T.4
Nakagami, K.5
Yuki, Y.6
Kiyono, H.7
-
71
-
-
82755165048
-
Type i IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation
-
22163016 10.1371/journal.pone.0028432 1:CAS:528:DC%2BC3MXhs1Khur7F 3232207
-
Zhang L, Yuan S, Cheng G, Guo B (2011) Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 6:e28432
-
(2011)
PLoS One
, vol.6
, pp. 28432
-
-
Zhang, L.1
Yuan, S.2
Cheng, G.3
Guo, B.4
-
72
-
-
34547188748
-
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
-
17581537 10.1038/ni1488 1:CAS:528:DC%2BD2sXptlSkurw%3D
-
Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967-974
-
(2007)
Nat Immunol
, vol.8
, pp. 967-974
-
-
Zhou, L.1
Ivanov, I.I.2
Spolski, R.3
Min, R.4
Shenderov, K.5
Egawa, T.6
Levy, D.E.7
Leonard, W.J.8
Littman, D.R.9
|